Cargando…

Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view

It is generally accepted that the current guidelines for the primary prevention of sudden arrhythmic death, which are based on ejection fraction, do not allow the optimal selection of patients with low left ventricular ejection fraction of ischemic and nonischemic etiology for implantation of a card...

Descripción completa

Detalles Bibliográficos
Autores principales:	Disertori, Marcello, Gulizia, Michele M., Casolo, Giancarlo, Delise, Pietro, Di Lenarda, Andrea, Di Tano, Giuseppe, Lunati, Maurizio, Mestroni, Luisa, Salerno-Uriarte, Jorge, Tavazzi, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768631/ https://www.ncbi.nlm.nih.gov/pubmed/26895401 http://dx.doi.org/10.2459/JCM.0000000000000368

Ejemplares similares

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death
por: Casolo, Giancarlo, et al.
Publicado: (2023)

Arrhythmic triad in an implantable cardioverter‐defibrillator recipient with severe hypokalemia
por: Ciriello, Giovanni Domenico, et al.
Publicado: (2022)

Arrhythmic Sudden Cardiac Death and the Role of Implantable Cardioverter-Defibrillator in Patients with Cardiac Amyloidosis—A Narrative Literature Review
por: Liżewska-Springer, Aleksandra, et al.
Publicado: (2021)

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
por: Ahmed, Imdad, et al.
Publicado: (2010)

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators
por: Sassone, Biagio, et al.
Publicado: (2021)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm
por: Sueda, Shozo, et al.
Publicado: (2018)

Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator
por: Wan, Chingping, et al.
Publicado: (2013)

Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients with Ventricular Arrhythmia of Unclear Cause in Secondary Prevention of Sudden Cardiac Death
por: Noordman, Alwin B. P., et al.
Publicado: (2023)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
por: Dehghani, Mohammad Reza, et al.
Publicado: (2006)

A comparison of anti‐arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter‐defibrillators
por: Ayan, Mohamed, et al.
Publicado: (2019)

Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2011)

Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
por: Apiyasawat, Sirin, et al.
Publicado: (2014)

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy
por: Wu, Katherine C., et al.
Publicado: (2020)

Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
por: Wäßnig, Nadine K., et al.
Publicado: (2016)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator
por: Skowasch, Dirk, et al.
Publicado: (2018)

Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
por: Kutyifa, Valentina, et al.
Publicado: (2018)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis
por: Nguyen, Elaine, et al.
Publicado: (2018)

Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Ventricular tachycardia-inducibility predicts arrhythmic events in post-myocardial infarction patients with low ejection fraction. A systematic review and meta-analysis
por: Disertori, Marcello, et al.
Publicado: (2018)

Appropriateness of Prescription and Safety of Wearable Cardioverter Defibrillators: A Single-center Experience
por: Sundhu, Murtaza, et al.
Publicado: (2019)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
por: Corrado, Egle, et al.
Publicado: (2020)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon
por: Couceiro, Katia do Nascimento, et al.
Publicado: (2021)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
por: Klopotowski, Mariusz, et al.
Publicado: (2022)

Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
por: Israel, Carsten, et al.
Publicado: (2022)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
por: Yuyun, Matthew F., et al.
Publicado: (2020)

Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients
por: Disertori, Marcello, et al.
Publicado: (2017)

Impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for implantable cardioverter defibrillators
por: Joshi, Subodh B, et al.
Publicado: (2011)

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
por: Rørth, Rasmus, et al.
Publicado: (2019)

Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility
por: Schiau, Călin, et al.
Publicado: (2021)

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022)

Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis
por: Andrié, René, et al.
Publicado: (2017)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
por: Lebedeva, Viktoria K., et al.
Publicado: (2018)

Refractory Vasospastic Angina and Sudden Cardiac Arrest: Is Implantable Cardioverter Defibrillator Indicated and Is It Always Protective?
por: Riaz, Sana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_56ld33g9ba45e8lj6gb8nt153v